First New Agent for CLL Patients Approved by the FDA since 2001 - March 21, 2008 - Cephalon

CEAT Ltd, the flagship company of the 13,500 crore RPG Group and one of India’s leading tyre manufacturers has today signed an agreement with M/s. Ashford InfoTech Limited for development of a vacant portion of about 7 acres of land located at Village Road in Bhandup, Mumbai. The proceeds of the... - March 12, 2008 - RPG

Proposed federal mandates in H.R. 1424 on health insurance offered by employers may drive up the cost of premiums and cause small companies to reduce or eliminate health insurance benefits. - March 07, 2008 - Zyto Corp.

The FDA has approved PRISTIQ (desvenlafaxine), an SNRI, to treat adult patients with major depressive disorder (MDD). Wyeth expects to begin shipping PRISTIQ to wholesalers beginning in the second quarter of 2008. - March 01, 2008 - Wyeth Pharmaceuticals

ZYTO Corp. uses an automated online reciprocal link software to improve search engine optimization. The use of the service saves time and money, and gets results, according to company officials. - February 15, 2008 - Zyto Corp.

Samaritan has appointed two new independent members, Jack L. Ayala and Robert W. Crane, to its Board of Directors. Mr. Ayala and Mr. Crane bring valuable experience and their appointment strengthens Samaritan's commitment to maintain a majority of independent members that reflects today's best practices on its Board. Samaritan's board is now comprised of eight independent directors and two internal directors. - January 09, 2008 - Samaritan Pharmaceuticals

Samaritan has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 09, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals has received a notice that a European Patent has been granted to Samaritan's SP-1000 (Cholesterol Recognition Sequence) drug for the treatment of cardiovascular disease. - January 09, 2008 - Samaritan Pharmaceuticals

Enters Service Agreement with Advinus Therapeutics, India to Validate Potential Memory Restoring Benefits of Alzheimer's Drug Caprospinol. Strategy is to Bolster Caprospinol Alzheimer's Data Package to Out-License to Big Pharma and Expand IND Application to Enter Human Trials. Samaritan Pharmaceuticals... - January 09, 2008 - Samaritan Pharmaceuticals

The U.S. Food and Drug Administration (FDA) has completed its regulatory review of Samaritan's IND (Investigational New Drug) application for Cushing's syndrome SP-6300 and declared it has not identified any deficiencies in its IND filing. Accordingly, Samaritan can proceed with its proposed Phase II clinical study of Cushing's syndrome SP-6300's efficacy in patients experiencing Hypercortisolism. - January 04, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals, Inc. is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification, from the Cyprus Ministry of Health, that its marketing authorization for HIV fungus drug Amphocil has been approved in Cyprus. The Cyprus Ministry of Health is... - January 03, 2008 - Samaritan Pharmaceuticals

Ms. Anna Strasberg has joined Samaritan's Advisory Board. Anna Strasberg is best known for continuing the Actors Studio, where the work of her husband Lee Strasberg nurtured the talents of celebrities like Marlon Brando, Robert De Niro, Harvey Keitel, Paul Newman and Al Pacino. - January 03, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 03, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals, Inc. has signed an exclusive distribution agreement with EUSA Pharma to launch, promote, sell and support pain patch Rapydan in Greece and Cyprus. - January 03, 2008 - Samaritan Pharmaceuticals

The annual art camp by the RPG Academy of Art concluded with a warm brunch at the Marve beach house today. Pristine white was the theme of the locale and the breezy touch of sea winds along with the live band playing some groovy numbers got the enchantment heightened. After the week-long camp, the participating... - December 30, 2007 - RPG

•Rs. 391 Crores win in Abu Dhabi; Largest single win ever, in dollar value terms, for KEC •Rs. 246 crores turnkey contract in Algeria - December 01, 2007 - RPG

•Rs. 260 Crores Turnkey contract in Saudi Arabia •Rs. 140 Crores Turnkey contract in Namibia - December 01, 2007 - RPG

In an in vivo 'Proof of Concept' study, Samaritan Pharmaceuticals, Inc. has confirmed Caprospinol's (SP-233) efficacy in its ability to dramatically decrease beta amyloid plaque in the brain, accompanied by a complete recovery of memory back to baseline (p=0.002), as shown in a Morris water maze task. This study confirms previously reported in vitro data and suggests Caprospinol may not only slow the progress of Alzheimer's, but may also reverse plaque-related brain injuries associated with AD. - November 27, 2007 - Samaritan Pharmaceuticals

Chiropractors using the latest biotechnology from ZYTO Corp. report success in the growth of their practice and a better ability to assess the needs of their patients. - November 01, 2007 - Zyto Corp.

In a comparison study between schizophrenia treatments INVEGA™ (paliperidone) Extended-Release Tablets and SEROQUEL® (quetiapine), Invega patients saw schizophrenia symptom improvements as early as five days into therapy and continued through the end of the two-week study period. Results were presented today at the 20th Annual U.S. Psychiatric and Mental Health Congress in Orlando, Florida. - October 13, 2007 - Johnson & Johnson

Successful Implementation of MedcomSoft Record results in HIMSS award - October 04, 2007 - MedcomSoft - Featured Press Release

Samaritan announced today the appointment of James E.K. Hildreth, M.D., a world renowned physician and HIV researcher, to its Scientific Advisory Board. The work of Dr. Hildreth in HIV/AIDS dates back to 1986 and focuses on blocking HIV infection by learning how HIV gets into cells. He has published more than 80 scientific articles and holds six patents. - October 03, 2007 - Samaritan Pharmaceuticals

Doctors Valdez, Amos and Burwell Showcase the Interoperable EHR - October 02, 2007 - MedcomSoft - Featured Press Release

Zyto biotechnology enables healthcare providers to use the newest bio-communications technology that enables a computer to actually talk to a patient’s body. The information gathered is used by healthcare workers to make better recommendations for health. - October 01, 2007 - Zyto Corp.

Denver alternative healthcare provider Annelle Norman of Vital Energy Clinic is using the latest biotechnology from ZYTO Corp. to guide people to a healthier life. Free demonstrations are available to the press. - September 29, 2007 - Zyto Corp.

Xymogen Inc. has created a new weight loss product designed to help anyone who wants to get lean, get healthy, and get fit. - August 25, 2007 - Zyto Corp.

ZYTO Corp. is the subject of an interview on WallSt.net featuring company founder Dr. Vaughn R. Cook. The interview is available for listening online. - August 23, 2007 - Zyto Corp.

Samaritan announced that it has entered into an exclusive licensing agreement with Georgetown University for a patent covering the Peripheral Benzodiazepine Receptor (PBR) which has led to Cancer drug candidates with the ability to inhibit cancerous tumors; and an imaging technique that could possibly distinguish cancerous tumors for a more targeted and improved chemotherapy. - August 21, 2007 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals has exclusively licensed a patent application entitled "Structure Based Drug Design of Steroid Inhibitors" from Georgetown University. - August 16, 2007 - Samaritan Pharmaceuticals

Xymogen Inc. executive board members have begun using Zyto technology in their own private practices after a demonstration at a recent board meeting. The company has begun marketing the technology to health care practitioners. - July 31, 2007 - Zyto Corp.

ZYTO Corp. has announced that it has entered into a strategic marketing agreement with XYMOGEN for the sale of ZYTO technology to XYMOGEN customers. The joint marketing agreement brings higher sales revenues to both companies. - July 28, 2007 - Zyto Corp.

ZYTO Corp. has announced that a marketing agreement with BioNativus for the sale of ZYTO technology to the health care practitioners who are customers of BioNativus has paid off in higher sales for both companies. - July 27, 2007 - Zyto Corp.

MedcomSoft Inc. (TSX-MSF), a provider of the next generation of interoperable electronic health records (EHR), today announced that quarterly sales of MedcomSoft Record licenses continue to surpass fiscal 2006 levels as the Company experiences sales growth across the country and among numerous specialties.... - July 11, 2007 - MedcomSoft - Featured Press Release

Zyto bio-technology enables healthcare providers to use a computer to communicate directly with a patient’s body. It is based on biology, quantum physics, energy medicine, galvanic skin response, and doctors of all kinds love it. - July 11, 2007 - Zyto Corp.

IPN Purchases 60 MedcomSoft Record licenses. MedcomSoft to Deploy Data Repository and Certify IPN Affiliate to Implement MedcomSoft Record - June 27, 2007 - MedcomSoft - Featured Press Release

Southeastern Pediatrics & Adolescent Medicine showcases interoperability benefits of standards based, numerically codified EMRs - June 27, 2007 - MedcomSoft - Featured Press Release

MedcomSoft Inc. (TSX-MSF), a provider of the next generation of interoperable electronic health records (EHR), announced today that it was ranked first overall in the Ambulatory EMR 1-5 Physicians category in KLAS’ 2007 Mid-Year Report. KLAS independently monitors vendor performance through the... - June 23, 2007 - MedcomSoft - Featured Press Release

ZYTO Corp. is pursuing a course to list company stock on NASDAQ. The company currently trades in the pink sheets. - May 31, 2007 - Zyto Corp.

ZYTO Corp. (OTC - ZYTC.pk) added two members to the board of directors after an election at the annual meeting of stockholders. The election followed a three-day conference attended by doctors and healthcare providers who use ZYTO technology. - May 11, 2007 - Zyto Corp.

MedcomSoft to release next generation of interoperable electronic health records at TEPR. - May 10, 2007 - MedcomSoft - Featured Press Release

University of Central Missouri (UCM) selects MedcomSoft Record EMR software. - May 02, 2007 - MedcomSoft - Featured Press Release

ZYTO Corp. has announced the annual meeting of stockholders will be on May 5, 2007. - April 22, 2007 - Zyto Corp.

Zyto Corp. (OTC - ZYTC.pk) has announced the addition of Dr. Jeff Wheelwright, DC, as a presenter at a three-day conference in Park City, Utah offered at no charge to healthcare professionals. - April 18, 2007 - Zyto Corp.

ZYTO Corp. (OTC - ZYTC.pk) has announced that Dr. Paul Ling Tai will address the healthcare practitioners at the annual ZYTO Conference on the subject of natural bio-phyto hormones for the ultimate anti-aging program. - April 13, 2007 - Zyto Corp.

MedcomSoft, a provider of Electronic Medical Records (EMR), announces Quarterly sales of flagship product MedcomSoft Record 2006 continues to surpass Fiscal 2006 levels. - April 12, 2007 - MedcomSoft - Featured Press Release

Zyto Corp. has announced plans for the company’s annual conference for healthcare practitioners to be held in Park City, Utah. There is no charge for participation. - April 07, 2007 - Zyto Corp.

Zyto Corp. began a marketing program in January that uses a strategic alliance of nutriceutical companies and their network of healthcare professionals. Members of the board of directors are pleased with the progress. - April 03, 2007 - Zyto Corp.

Advaxis’ John Rothman Recognized as one of 20 Notable People in R&D - March 16, 2007 - Advaxis

In insomnia news, actor and insomnia sufferer, Cheryl Hines, joins the American Academy of Nurse Practitioners (AANP) Foundation to pull the covers off chronic insomnia. “Why Count on Sheep to Sleep?”, an educational initiative, supported by Sanofi-Aventis, raises awareness of sleep problems, causes of insomnia, and provides people with sleep solutions. Sleep disorders can be a serious medical condition characterized by difficulty falling asleep and staying asleep. - March 10, 2007 - Sanofi-Aventis

Pro-Tect, Inc. (PRTT.PK) announced today that it has entered into a licensing agreement with American Natural Technology Sciences (ANTS) for the marketing rights to Mitigator's® technology. - March 09, 2007 - Pro-Tect, Inc.